EP4440577A4 - Composition à libération retardée comprenant de la doxylamine et de la pyridoxine - Google Patents

Composition à libération retardée comprenant de la doxylamine et de la pyridoxine

Info

Publication number
EP4440577A4
EP4440577A4 EP21966535.3A EP21966535A EP4440577A4 EP 4440577 A4 EP4440577 A4 EP 4440577A4 EP 21966535 A EP21966535 A EP 21966535A EP 4440577 A4 EP4440577 A4 EP 4440577A4
Authority
EP
European Patent Office
Prior art keywords
pyridoxin
doxylamine
delayed
release composition
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21966535.3A
Other languages
German (de)
English (en)
Other versions
EP4440577A1 (fr
Inventor
Hatice Oncel
Onur Pinarbasli
Feristah Bilgin
Ozgen Bahar Koksel
Nurdan Atilgan
Doganay Asuman Aybey
Nagehan Sarracoglu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ilko Ilac Sanayi ve Ticaret AS
Original Assignee
Ilko Ilac Sanayi ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ilko Ilac Sanayi ve Ticaret AS filed Critical Ilko Ilac Sanayi ve Ticaret AS
Publication of EP4440577A1 publication Critical patent/EP4440577A1/fr
Publication of EP4440577A4 publication Critical patent/EP4440577A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
EP21966535.3A 2021-11-30 2021-11-30 Composition à libération retardée comprenant de la doxylamine et de la pyridoxine Pending EP4440577A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/TR2021/051318 WO2023101620A1 (fr) 2021-11-30 2021-11-30 Composition à libération retardée comprenant de la doxylamine et de la pyridoxine

Publications (2)

Publication Number Publication Date
EP4440577A1 EP4440577A1 (fr) 2024-10-09
EP4440577A4 true EP4440577A4 (fr) 2025-11-05

Family

ID=86612891

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21966535.3A Pending EP4440577A4 (fr) 2021-11-30 2021-11-30 Composition à libération retardée comprenant de la doxylamine et de la pyridoxine

Country Status (2)

Country Link
EP (1) EP4440577A4 (fr)
WO (1) WO2023101620A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2432945A1 (fr) * 2003-07-10 2003-09-28 Duchesnay Inc. Utilisation d'un succinate de doxylamine et de chlorhydrate de pyridoxinium pour la prophylaxie et le traitement des nausees post-chirurgical
WO2013082706A1 (fr) * 2011-12-07 2013-06-13 Pharmascience Inc. Formulation de doxylamine et de pyridoxine à libération prolongée sans délitant et procédé de fabrication associé
CN103432126A (zh) * 2013-08-05 2013-12-11 北京阜康仁生物制药科技有限公司 一种治疗孕吐的药物组合物

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2432945A1 (fr) * 2003-07-10 2003-09-28 Duchesnay Inc. Utilisation d'un succinate de doxylamine et de chlorhydrate de pyridoxinium pour la prophylaxie et le traitement des nausees post-chirurgical
WO2013082706A1 (fr) * 2011-12-07 2013-06-13 Pharmascience Inc. Formulation de doxylamine et de pyridoxine à libération prolongée sans délitant et procédé de fabrication associé
CN103432126A (zh) * 2013-08-05 2013-12-11 北京阜康仁生物制药科技有限公司 一种治疗孕吐的药物组合物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2023101620A1 *

Also Published As

Publication number Publication date
WO2023101620A1 (fr) 2023-06-08
EP4440577A1 (fr) 2024-10-09

Similar Documents

Publication Publication Date Title
EP3565397A4 (fr) Compositions microbiennes et procédés
KR102090294B9 (ko) 가소제 조성물 및 이를 포함하는 수지 조성물
EP3564714A4 (fr) Composition de formation de couche de revêtement dur et lentille de lunettes
MA41794A (fr) Agents thérapeutiques modifiés et compositions associées
EP4151246A4 (fr) Composition anti-adhérence
EP3831877A4 (fr) Composition contenant un fluoropolymère et article moulé
EP3565396A4 (fr) Compositions microbiennes et procédés associés
EP3478827C0 (fr) Variants de lipase et compositions comprenant un tensioactif et un variant de lipase
PL3352766T3 (pl) Kompozycie z hialuronanem o dużej elastyczności i sposoby ich użycia
EP3310376A4 (fr) Agents thérapeutiques modifiés et compositions associées
EP3705531A4 (fr) Composition durcissable
EP3498777A4 (fr) Composition d'émulsion d'organopolysiloxane, et composition de résine
EP3336121A4 (fr) Composition durcissable et article durci associé
PL3393485T3 (pl) Kompozycje probiotyczne i ich zastosowanie
IL271073A (en) B4galt1 variants and uses thereof
EP3705529A4 (fr) Composition durcissable
EP3560969A4 (fr) Composition durcissable
EP3660103A4 (fr) Composition et composition de résine ignifuge
EP3705527A4 (fr) Composition durcissable
EP3594285A4 (fr) Composition, et film de revêtement
EP3336122A4 (fr) Composition durcissable et article durci associé
EP4221735C0 (fr) Composition comprenant des monomeres de flavanol et de l'e-viniferine
EP3705530A4 (fr) Composition durcissable
DK3436515T3 (da) Byggemateriale med kontrolleret porøsitet og med nanocellulosefibre
EP3312212A4 (fr) Composition durcissable

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20240528

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20251007

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/4402 20060101AFI20250930BHEP

Ipc: A61K 31/4415 20060101ALI20250930BHEP

Ipc: A61K 9/20 20060101ALI20250930BHEP

Ipc: A61P 1/08 20060101ALI20250930BHEP

Ipc: A61K 9/28 20060101ALI20250930BHEP